http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#head http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#assertion http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#provenance http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#publicationInfo http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#assertion http://bio2rdf.org/drugbank:DB00242 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://bio2rdf.org/drugbank:DB01097 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://purl.org/dc/terms/identifier drugbank_resource:DB00242_DB01097 http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://purl.org/dc/terms/title DDI between Cladribine and Leflunomide - Immunosuppressants such as cladribine may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00242_DB01097 http://www.w3.org/2000/01/rdf-schema#label DDI between Cladribine and Leflunomide - Immunosuppressants such as cladribine may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. [drugbank_resource:DB00242_DB01097] http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#provenance http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#publicationInfo http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#signature.MCwCFHYBaPpRXIwO http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#signature.MCwCFHYBaPpRXIwO http://purl.org/nanopub/x/hasSignature MCwCFHYBaPpRXIwOcgKW6w2ub24QYWIWAhRpe7DRxo9rWFC7eaTKdCm4ERLh4Q== http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#signature.MCwCFHYBaPpRXIwO http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://purl.org/dc/terms/created 2018-03-30T11:12:26.789+02:00 http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo#signature.MCwCFHYBaPpRXIwO http://bio2rdf.org/drugbank_resource:DB00242_DB01097_nanopub.RAxKWuM7I2EDkItRuc9B3xqYKGiArSj2Xek6r8zw2tbTo http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234